{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T03:05:36Z","timestamp":1780455936800,"version":"3.54.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T00:00:00Z","timestamp":1763424000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s11655-025-4024-5","type":"journal-article","created":{"date-parts":[[2025,11,18]],"date-time":"2025-11-18T14:42:01Z","timestamp":1763476921000},"page":"553-559","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk Factors for Severity of Adverse Events Associated with Xuebijing Injection: A Propensity Score-Matched Analysis"],"prefix":"10.1007","volume":"32","author":[{"given":"Rui","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-ying","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-qian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-rong","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-cai","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,18]]},"reference":[{"key":"4024_CR1","first-page":"54","volume":"127","author":"T Smith","year":"2020","unstructured":"Smith T, May G, Eckl V, Morton Reynolds C. US sales of herbal supplements increase by 8.6% in 2019. Herbal Gram 2020;127:54\u201369.","journal-title":"Herbal Gram"},{"key":"4024_CR2","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1001\/jamainternmed.2023.0780","volume":"183","author":"S Liu","year":"2023","unstructured":"Liu S, Yao C, Xie J, Liu H, Wang H, Lin Z, et al. Effect of an herbal-based injection on 28-day mortality in patients with sepsis: the EXIT-SEP randomized clinical trial. JAMA Intern Med 2023;183:647\u2013655.","journal-title":"JAMA Intern Med"},{"key":"4024_CR3","doi-asserted-by":"publisher","first-page":"e735","DOI":"10.1097\/CCM.0000000000003842","volume":"47","author":"Y Song","year":"2019","unstructured":"Song Y, Yao C, Yao Y, Han H, Zhao X, Yu K, et al. Xuebijing Injection versus placebo for critically ill patients with severe community-acquired pneumonia: a randomized controlled trial. Crit Care Med 2019;47:e735\u2013e743.","journal-title":"Crit Care Med"},{"key":"4024_CR4","first-page":"1114","volume":"40","author":"Chinese Association of Traditional Chinese Medicine.","year":"2024","unstructured":"Chinese Association of Traditional Chinese Medicine. Guidelines for integrated traditional Chinese and Western medicine diagnosis and treatment of severe acute pancreatitis. J Clin Hepatobiliary (Chin) 2024;40:1114\u20131125.","journal-title":"J Clin Hepatobiliary (Chin)"},{"key":"4024_CR5","first-page":"1575","volume":"40","author":"J Xiaoyu","year":"2023","unstructured":"Xiaoyu J, Yue Z, Jie C. Selection evaluation of Xuebijing Injection by the Experts Consensus on the Selection of Chinese Patent Medicine. Tianjin J Tradit Chin Med (Chin) 2023;40:1575\u20131580.","journal-title":"Tianjin J Tradit Chin Med (Chin)"},{"key":"4024_CR6","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.joim.2024.08.006","volume":"22","author":"Z Gong","year":"2024","unstructured":"Gong Z, Yang H, Zhu B, Liu H, Siri G. Clinical efficacy of Xuebijing Injection for the treatment of sepsis: a retrospective cohort study. J Integr Med 2024;22:645\u2013651.","journal-title":"J Integr Med"},{"key":"4024_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.fitote.2018.07.009","volume":"129","author":"H Li","year":"2018","unstructured":"Li H, Wang S, Yue Z, Ren X, Xia J. Traditional Chinese herbal injection: current status and future perspectives. Fitoterapia 2018;129:249\u2013256.","journal-title":"Fitoterapia"},{"key":"4024_CR8","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/j.biopha.2018.10.190","volume":"109","author":"C Wang","year":"2019","unstructured":"Wang C, Shi QP, Ding F, Jiang XD, Tang W, Yu ML, et al. Reevaluation of the post-marketing safety of Xuebijing Injection based on real-world and evidence-based evaluations. Biomed Pharmacother 2019;109:1523\u20131531.","journal-title":"Biomed Pharmacother"},{"key":"4024_CR9","first-page":"1385","volume":"44","author":"Z Chen","year":"2021","unstructured":"Chen Z, Zheng R, Zhang X Z, Qiu R, Pan H, Sun Y, et al. Study on liver injury of combined use of Xuebijing Injection and three kinds of antibiotics based on zebrafish model. Drug Eval Res (Chin) 2021;44:1385\u20131391.","journal-title":"Drug Eval Res (Chin)"},{"key":"4024_CR10","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet 2000;356:1255\u20131259.","journal-title":"Lancet"},{"key":"4024_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s40588-023-00194-6","volume":"10","author":"P Shrivastava","year":"2023","unstructured":"Shrivastava P, Gothalwal R, Gandhi P. Therapeutic strategies to ameliorate antibiotic resistance and hosti-nflammation response in sepsis: an innovative approach. Curr Clin Microbiol Rep 2023;10:85\u201398.","journal-title":"Curr Clin Microbiol Rep"},{"key":"4024_CR12","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3389\/fphar.2020.00104","volume":"11","author":"T Li","year":"2020","unstructured":"Li T, Qian Y, Miao Z, Zheng P, Shi T, Jiang X, et al. Xuebijing Injection alleviates Pam3CSK4-induced inflammatory response and protects mice from sepsis caused by methicillin-resistant Staphylococcus aureus. Front Pharmacol 2020;11:104.","journal-title":"Front Pharmacol"},{"key":"4024_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1046\/j.1365-2125.2003.01875.x","volume":"57","author":"PA Routledge","year":"2004","unstructured":"Routledge PA, O\u2019Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004;57:121\u2013126.","journal-title":"Br J Clin Pharmacol"},{"key":"4024_CR14","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/j.apsb.2019.06.003","volume":"9","author":"J Li","year":"2019","unstructured":"Li J, Olaleye OE, Yu X, Jia W, Yang J, Lu C, et al. High degree of pharmacokinetic compatibility exists between the five-herb medicine Xuebijing and antibiotics comedicated in sepsis care. Acta Pharm Sin B 2019;9:1035\u20131049.","journal-title":"Acta Pharm Sin B"},{"key":"4024_CR15","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1016\/j.apsb.2023.06.001","volume":"13","author":"L Ye","year":"2023","unstructured":"Ye L, Fan S, Zhao P, Wu C, Liu M, Hu S, et al. Potential herb-drug interactions between anti-COVID-19 drugs and traditional Chinese medicine. Acta Pharm Sin B 2023;13:3598\u20133637.","journal-title":"Acta Pharm Sin B"},{"key":"4024_CR16","doi-asserted-by":"publisher","first-page":"153305","DOI":"10.1016\/j.phymed.2020.153305","volume":"78","author":"C Wang","year":"2020","unstructured":"Wang C, Gao Y, Zhang Z, Chi Q, Liu Y, Yang L, et al. Safflower yellow alleviates osteoarthritis and prevents inflammation by inhibiting PGE2 release and regulating NF-\u03baB\/SIRT1\/AMPK signaling pathways. Phytomedicine 2020;78:153305.","journal-title":"Phytomedicine"},{"key":"4024_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1177\/0394632015617065","volume":"29","author":"XW Yang","year":"2016","unstructured":"Yang XW, Li YH, Zhang H, Zhao YF, Ding ZB, Yu JZ, et al. Safflower yellow regulates microglial polarization and inhibits inflammatory response in LPS-stimulated Bv2 cells. Int J Immunopathol Pharmacol 2016;29:54\u201364.","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4024_CR18","first-page":"401","volume":"34","author":"J Wang","year":"2020","unstructured":"Wang J, Zhang Y, Wang J, Liu R, Zhang G, Dong K, et al. Paeoniflorin inhibits MRGPRX2-mediated pseudo-allergic reaction via calcium signaling pathway Phytother Res 2020;34:401\u2013408.","journal-title":"Paeoniflorin inhibits MRGPRX2-mediated pseudo-allergic reaction via calcium signaling pathway Phytother Res"},{"key":"4024_CR19","doi-asserted-by":"publisher","first-page":"112424","DOI":"10.1016\/j.jep.2019.112424","volume":"250","author":"R Zheng","year":"2020","unstructured":"Zheng R, Tao L, Kwong JSW, Zhong C, Li C, Chen S, et al. Risk factors associated with the severity of adverse drug reactions by Xiyanping Injection: a propensity score-matched analysis. J Ethnopharmacol 2020;250:112424.","journal-title":"J Ethnopharmacol"},{"key":"4024_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1542-2011.2010.00050.x","volume":"56","author":"N Tharpe","year":"2011","unstructured":"Tharpe N. Adverse drug reactions in women\u2019s health care. J Midwifery Womens Health 2011;56:205\u2013213.","journal-title":"J Midwifery Womens Health"},{"key":"4024_CR21","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40263-024-01088-x","volume":"38","author":"L Giuliano","year":"2024","unstructured":"Giuliano L, Durante V, Battaglia G, Gasparini S, Zambrelli E, Ermio C, et al. Sex differences in adverse effects of antiseizure medications in adults with epilepsy: a systematic review. CNS Drugs 2024;38:409\u2013423.","journal-title":"CNS Drugs"},{"key":"4024_CR22","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2165\/00002018-200629070-00004","volume":"29","author":"W Aichhorn","year":"2006","unstructured":"Aichhorn W, Whitworth AB, Weiss EM, Marksteiner J. Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles? Drug Saf 2006;29:587\u2013598.","journal-title":"Drug Saf"},{"key":"4024_CR23","doi-asserted-by":"publisher","first-page":"19150","DOI":"10.1038\/s41598-021-98689-z","volume":"11","author":"S Yoon","year":"2021","unstructured":"Yoon S, Jeong S, Jung E, Kim KS, Jeon I, Lee Y, et al. Effect of CYP3A4 metabolism on sex differences in the pharmacokinetics and pharmacodynamics of zolpidem. Sci Rep 2021;11:19150.","journal-title":"Sci Rep"},{"key":"4024_CR24","doi-asserted-by":"publisher","first-page":"117","DOI":"10.21037\/atm.2018.09.26","volume":"7","author":"R Zheng","year":"2019","unstructured":"Zheng R, Wang H, Liu Z, Wang X, Li J, Shang H. A real-world study on adverse drug reactions to Xuebijing Injection: hospital intensive monitoring based on 93 hospitals (31,913 cases). Ann Transl Med 2019;7:117.","journal-title":"Ann Transl Med"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-4024-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-025-4024-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-025-4024-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:39:58Z","timestamp":1780454398000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-025-4024-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,18]]},"references-count":24,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["4024"],"URL":"https:\/\/doi.org\/10.1007\/s11655-025-4024-5","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,18]]},"assertion":[{"value":"22 July 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}